Efficacy of Treatment for Latent Tuberculosis in Patients Undergoing Treatment with a Tumor Necrosis Factor Antagonist-Reference-Cited by-同舟云学术

Efficacy of Treatment for Latent Tuberculosis in Patients Undergoing Treatment with a Tumor Necrosis Factor Antagonist

Published:2017-05 Issue:5 Volume:14 Page:690-697
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Lee Jungsil¹^ORCID,Kim Eunyoung²,Jang Eun Jin³,Lee Chang-Hoon⁴,Lee Eun Young²,Im Jong Pil³,Han Sung Koo⁴⁵,Yim Jae-Joon⁴⁵

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea

2. Department of Statistics, Kyungpook National University, Daegu, Republic of Korea

3. Department of Information Statistics, Andong National University, Andong, Republic of Korea

4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea

5. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201608-647OC

Reference41 articles.

1. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

2. Priorities for the Treatment of Latent Tuberculosis Infection in the United States

3. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea;International Journal of Infectious Diseases;2024-04

2. Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications;Biological and Pharmaceutical Bulletin;2023-12-01

3. Tuberculosis infection following immune checkpoint inhibitor treatment for advanced cancer: a case report and literature review;Frontiers in Immunology;2023-05-25

4. New‐onset extrapulmonary tuberculosis in negative latent tuberculosis infection screening patients with Crohn's disease under anti‐TNF therapy in a tuberculosis‐endemic region: A case series;Journal of Digestive Diseases;2023-05

5. Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013–2018;Arthritis Research & Therapy;2022-06-27